To treat or not to treat? : dilemmas when deciding on antineoplastic treatment in patients with far advanced cancers

Article

PAIVA, Carlos Eduardo | D'ALMEIDA PRETO, Daniel | DE LIMA, Crislaine | SAKAMOTO RIBEIRO PAIVA, Bianca

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative review, we will explore the decision-making process for patients with advanced cancers and provide insights on how to approach this complex task, while didactically dividing the oncologist's assessments according to a mnemonic rule of the ABCDE of therapeutic decision-making. Part A (advanced cancer) recalls that the rule is to be used specifically for advanced cancers. Parts B (potential benefits) and C (clinical conditions and risks) represents the traditional risk vs benefit scale. In Part D, we discuss ways to identify and understand patients' desires, values, preferences, and beliefs. The prognostic estimation, from Part E, may function as an "adjust" for the antineoplastic treatment decision-making. Treatment decisions need to be conducted by skilled oncologists, in a patient-centered care, aiming to promote valuable oncology with lower rates of aggressive care.

http://dx.doi.org/10.1177/10732748231176639

Voir la revue «Cancer control, 30»

Autres numéros de la revue «Cancer control»

Consulter en ligne

Suggestions

Du même auteur

To treat or not to treat? : dilemmas when dec...

Article indépendant | PAIVA, Carlos Eduardo | Cancer control | vol.30

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative rev...

To treat or not to treat? : dilemmas when dec...

Article indépendant | PAIVA, Carlos Eduardo | Cancer control | vol.30

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative rev...

Pharmacologic management of end-of-life delir...

Article indépendant | HUI, David | Cancers | n°11 | vol.16

End-of-life delirium affects a vast majority of patients before death. It is highly distressing and often associated with restlessness or agitation. Unlike delirium in other settings, it is considered irreversible, and non-pharmac...

De la même série

From hospital-centered care to home-centered ...

Article indépendant | POKSINSKA, Bonnie | Journal of health organization and management | n°9 | vol.38

PURPOSE: Providing high-quality and cost-efficient care of older people is an important development priority for many health and social care systems in the world. This paper suggests a shift from acute, episodic and reactive hospi...

Organisational learning through a charitable ...

Article indépendant | LEUNG, Tiffany Cheng Han | Journal of health organization and management | n°6 | vol.38

PURPOSE: We identify lessons from a project sponsored by a large charitable trust, which sought to build capability for end-of-life (EOL) care in Hong Kong through interdisciplinary and multi-agency collaboration. DESIGN/METHODOLO...

A realist evaluation of a “single point...

Article indépendant | EFSTATHIOU, Nikolaos | Journal of health organization and management | n°4 | vol.34

Purpose: Following the development of a service that consisted of a “single point of contact” to coordinate end-of-life care (EoLC), including EoLC facilitators and an urgent response team, we aimed to explore whether ...

Patients' trajectory with lung cancer from tr...

Article | OGURA, Yuri | Cancer control | vol.31

INTRODUCTION: This study aimed to describe the course of patients with lung cancer from treatment initiation to end-of-life. METHODS: This retrospective cohort study used Claims Data from the National Health Insurance and Advanced...

To treat or not to treat? : dilemmas when dec...

Article | PAIVA, Carlos Eduardo | Cancer control | vol.30

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative rev...

Chargement des enrichissements...